MANAGED CARE-FORMULARY CHANGES Senate SponsorsSen. Elgie R. Sims, Jr. 1/9/2019SenateSession Sine Die 215 ILCS 134/45.3 newAmends the Managed Care Reform and Patient Rights Act. Requires a policy or plan sponsor to notify the prescribing physician and the patient in writing 60 days before making a formulary change that alters the terms of coverage or discontinues coverage for a prescribed drug that the patient is receiving. Contains provisions for receiving the notice electronically. Provides that a policy or plan sponsor may provide the patient with the written notification, along with a 60-day supply of the prescription drug, at the time the patient requests a refill. Provides that nothing in the provisions prohibits insurers or pharmacy benefit managers from using certain managed pharmacy care tools so long as an exception process is in place allowing the prescriber to petition for coverage a non-preferred drug if sufficient clinical reasons justify an exception to the normal protocol. 2/16/2018SenateFiled with Secretary by Sen. Elgie R. Sims, Jr. 2/16/2018SenateFirst Reading 2/16/2018SenateReferred to Assignments 2/27/2018SenateAssigned to Insurance 4/13/2018SenateRule 2-10 Committee Deadline Established As April 27, 2018 4/27/2018SenateRule 3-9(a) / Re-referred to Assignments 1/9/2019SenateSession Sine Die